C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2013
12/11/2013	CN103435683A SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same
12/11/2013	CN103435682A Wheat germ protein source antioxidative peptide, and preparation method and application thereof
12/11/2013	CN102675426B Extraction and purification method of daptomycin
12/11/2013	CN102464704B Novel compound, its preparation method and application
12/11/2013	CN101636408B 肽 Peptide
12/10/2013	US8604166 Melanoma antigen peptide and uses thereof
12/10/2013	US8604165 Influenza inhibiting compositions and methods
12/10/2013	US8604164 High purity lipopeptides
12/10/2013	US8604163 EEF2K assays for identifying compounds that inhibit EEF2K activity
12/10/2013	US8604161 Prion protein ligands and methods of use
12/10/2013	US8603967 Carrier peptide fragment and use thereof
12/10/2013	CA2570396C Antibacterial peptides and analogues thereof
12/05/2013	WO2013181339A2 Cyclosporin a analogs
12/05/2013	WO2013180011A1 Anti-bacterial peptide and use thereof
12/05/2013	WO2013177922A1 Polypeptide for treating alzheimer's disease and genetic vaccine
12/05/2013	US20130326728 Agents for increased resistance against oxidative stress conditions
12/05/2013	US20130324482 Compstatin analogs for treatment of rhinosinusitis and nasal polyposis
12/05/2013	US20130324480 Cyclosporin a analogs
12/05/2013	US20130324476 Cosmetic use of dermicidin, and analogues or fragments thereof
12/05/2013	US20130324467 Neuropeptide analogs, compositions, and methods for treating pain
12/05/2013	US20130323254 Therapeutic anti-tirc7 antibodies for use in immune related and other diseases
12/05/2013	US20130323244 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
12/05/2013	US20130323187 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
12/05/2013	US20130323171 Radiolabeled bbn analogs for pet imaging of gastrin-releasing peptide receptors
12/05/2013	DE102012102998B4 New polymer comprising two substances that bind to amyloid-beta-oligomers, useful for treating Alzheimer's disease, Parkinson's disease, Creutzfeldt Jakob disease or diabetes
12/05/2013	CA2779949A1 Peptidomimetics comprising n-amino cyclic urea residues and uses thereof
12/04/2013	EP2668958A1 Caspofungin analog and applications thereof
12/04/2013	EP2668200A1 Glycogen synthase kinase-3 inhibitors
12/04/2013	EP2668199A2 Glycogen synthase kinase-3 inhibitors
12/04/2013	CN103421746A Monoclonal antibody EEEV-5E4 resisting EEEV E2 protein, B-cell epitope peptide recognized by EEEV-5E4 as well as application of EEEV-5E4 and B-cell epitope peptide
12/04/2013	CN103421745A Monoclonal antibody EEEV-6E2 resisting EEEV E2 protein, B-cell epitope peptide recognized by EEEV-6E2 as well as application of EEEV-6E2 and B-cell epitope peptid
12/04/2013	CN103421744A Monoclonal antibody (EEEV-5F4) resisting EEEV I E2 protein, B-cell epitope peptide recognized by EEEV-5F4 as well as application of EEEVI-5F4 and B-cell epitope peptide
12/04/2013	CN103421118A CTL epitope peptide of HTNV-Gn/Gc specificity and polymer and application thereof
12/04/2013	CN103421092A Atosiban purification method
12/04/2013	CN103421091A Anti-caries enamel matrix protein functional polypeptide and preparation method and application thereof
12/04/2013	CN103421090A Novel antimicrobial peptide
12/04/2013	CN103421089A Method for preparing Enramycin A and B hydrochloride mixture
12/04/2013	CN103421088A Solid-phase synthesis method for monocyte migration inhibitory factor
12/04/2013	CN103421087A Liquid-phase synthesizing method for polypeptide
12/04/2013	CN103421086A Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
12/04/2013	CN103421085A Oligopeptide used for increasing solubilities of paclitaxel or similar medicines based on paclitaxel structure
12/04/2013	CN103421084A Antibacterial compound
12/04/2013	CN102924574B Antibacterial peptide LZ1 and application of antibacterial peptide in preparation of antibacterial medicament
12/04/2013	CN102675425B Functional mycobacterium tuberculosis antigen polypeptide and application thereof
12/04/2013	CN102653554B Functional mycobacterium tuberculosis antigen polypeptide and application thereof
12/04/2013	CN102516358B Angiotensin I transferase inhibitor derived from scale collagen and application thereof
12/03/2013	US8598315 Protein transduction domains derived from secretory leukocyte protease inhibitor
12/03/2013	US8598314 Peptide-peptidase-inhibitor conjugates and methods of making and using same
12/03/2013	US8598312 Inhibitors of antigen presentation by MHC class II molecules
12/03/2013	US8598127 Peptides for inhibiting MDM2 function
12/03/2013	US8598126 Peptides for inhibiting the HPV-E6 oncoprotein
12/03/2013	US8598124 Peptides derived from HMG-CoA reductase and cosmetic and/or pharmaceutical composition containing same
12/03/2013	US8597657 Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins
12/03/2013	CA2566481C Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities
12/03/2013	CA2491607C Plant peptide with antimicrobial activity
12/03/2013	CA2420355C Novel polypeptide and process for producing the same
11/2013
11/28/2013	WO2013177231A1 Translocation of non-natural chemical entities through anthrax protective antigen pore
11/28/2013	WO2013176563A1 Biologically active peptide complexes
11/28/2013	WO2013175258A1 Novel melanoma antigen peptide and uses thereof
11/28/2013	WO2013175256A1 Novel melanoma antigen peptide and uses thereof
11/28/2013	WO2013174909A1 Purification of [18f] - fluciclatide
11/28/2013	WO2013173941A1 Peptide and the use thereof
11/28/2013	US20130317196 Triazanonane derivatives or pharmaceutically acceptable salt thereof for enhanced fluorine-18 labeling
11/28/2013	US20130317195 Her2delta16 peptides
11/28/2013	US20130316964 Aromatic-cationic peptides and uses of same
11/28/2013	US20130316961 Treatment of mecp-2 associated disorders
11/28/2013	US20130316956 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
11/28/2013	US20130316951 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
11/28/2013	US20130316945 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/28/2013	US20130316448 Peptides and related molecules that modulate nerve growth factor activity
11/28/2013	US20130315920 Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
11/28/2013	US20130315916 Respiratory syncytial virus vaccine
11/28/2013	US20130315856 Conjugates for the treatment of mesothelioma
11/28/2013	US20130315828 Kit and method of use of targeting peptide for diagnosis and therapy of cancer
11/28/2013	CA2874258A1 Peptide and the use thereof
11/27/2013	EP2666864A1 Genes that increase plant oil and method for using the same
11/27/2013	EP2666863A1 Genes that increase plant oil and method for using the same
11/27/2013	EP2666862A1 Genes that increase plant oil and method for using the same
11/27/2013	EP2666861A1 Genes that increase plant oil and method for using the same
11/27/2013	EP2666860A1 Genes that increase plant oil and method for using the same
11/27/2013	EP2666780A1 Biotin-linked hexapeptide-2 derivative and uses thereof
11/27/2013	EP2666474A1 Peptides and related molecules that modulate nerve growth factor activity
11/27/2013	EP2666473A1 Peptides and related molecules that modulate nerve growth factor activity
11/27/2013	EP2665747A1 Methods for treating disorders that involve immunoglobulin a
11/27/2013	EP2665744A2 Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation
11/27/2013	EP2665743A1 Novel ubiquitin-isopeptide probes
11/27/2013	EP2665486A1 Compositions and mehthods for modulating gamma-c-cytokine activity
11/27/2013	CN103415530A Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
11/27/2013	CN103408637A Preparation method of eptifibatide
11/27/2013	CN102731617B Hantavirus glucoprotein specific T cell epitope peptide and application thereof
11/27/2013	CN102399266B Immunogenic peptide of humvoltage-gated potassium channel 1.5 (hKv1.5) and purpose thereof
11/27/2013	CN102391168B Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
11/27/2013	CN102127155B Preparation of somatostatin peptides
11/26/2013	US8592379 Metastin derivative and use thereof
11/26/2013	US8592377 Stitched polypeptides
11/26/2013	US8591907 Hypoallergenic variants of the major allergen from Betula verrucosa pollen
11/26/2013	CA2631716C Targeting vector-phospholipid conjugates
11/26/2013	CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/21/2013	WO2013173755A1 Modification of peptides using a bis(thioether)arylbridge approach
11/21/2013	WO2013173410A2 Affinity peptides toward infliximab

1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 423